Use of capsule endoscopy in inflammatory bowel disease in clinical practice in Spain. Results from a national survey

Elosua, Alfonso; Castillejo, Óscar Nantes; Sainz, Ignacio Fernández-Urién; López-García, Alicia; Pomares, Óscar Murcia; Abdo, Y. Zabana

doi:10.1016/j.gastre.2021.02.006

Cited by 2 publications

(2 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Suspicion of CD is the most common indication of VCE in IBD as per a Spanish physician survey. 37 The diagnostic yield was highly variable (6–80%) across these studies. This wide variability can be explained by the heterogeneity of study design, variable definitions of suspected CD, pretest probability in the subjects studied, and variable age groups (includes pediatric).…”

Section: Resultsmentioning

confidence: 93%

Capsule Endoscopy in Inflammatory Bowel Disease: A Systematic Review

Pal,

Banerjee,

Gupta

et al. 2023

Journal of Digestive Endoscopy

View full text Add to dashboard Cite

The role of video capsule endoscopy (VCE) in inflammatory bowel disease (IBD) has evolved from small bowel to a panenteric evaluation tool over the past two decades. We systematically reviewed the techniques, applications, outcomes, and complications of VCE in IBD. A systematic literature search was performed using PubMed, Embase, and Medline. All relevant original articles involving VCE in IBD were included from 2003 to July 2022. After screening 3,089 citations, finally 201 references were included. The diagnostic yield of VCE in suspected Crohn's disease (CD) was highly variable (6–80%) with excellent sensitivity (77–93%) and specificity (80–89%). The diagnostic yield in known CD was 52 to 88.3% leading to a change in management (26–75%) and disease reclassification with variable retention rates. VCE was superior to small bowel series, computed tomography (CT) and could be better than magnetic resonance enterography (MRE), especially for proximal and superficial lesions. Colon or panenteric VCE has strong correlation to ileo-colonoscopy (IC) and combined magnetic resonance imaging and IC, respectively. The VCE retention rate in CD is higher in known CD which significantly decreases after the negative patency capsule test or CT/MRE. VCE can identify lesions beyond the reach of IC in postoperative CD. Colon Capsule Endoscopy is a noninvasive monitoring tool in ulcerative colitis (UC) having a strong correlation with IC and may uncover small bowel involvement. VCE is specifically useful in IBD-unclassified (IBD-U) which can lead to the diagnosis of CD in 16.7 to 61.5%. Various scoring systems have been established and validated for small bowel CD (Lewis score and capsule endoscopy CD activity index—CECDAI), UC (capsule scoring of UC: Capsule Scoring of Ulcerative Colitis), panenteric evaluation (Capsule Endoscopy Crohn's Disease Activity Index, Elaikim score), and flare prediction (APEX score). Technological advances include double head, three-dimensional reconstruction, sampling system, panoramic view (344 and 360 degree lateral), and panenteric capsule. Artificial intelligence and software like TOP100 and Quickview can help reduce capsule reading time with excellent sensitivity and specificity. VCE in IBD has widespread application in suspected and known small bowel CD, monitoring of UC, postoperative CD, IBD-U, and for panenteric evaluation. Patency capsule testing helps to reduce retention rates significantly. Artificial intelligence and technical advances can help evolve this novel technology.

show abstract

Section: Resultsmentioning

confidence: 93%

Capsule Endoscopy in Inflammatory Bowel Disease: A Systematic Review

Pal,

Banerjee,

Gupta

et al. 2023

Journal of Digestive Endoscopy

View full text Add to dashboard Cite

show abstract

“…SBCE, a safe and painless endoscopic method for the evaluation of the small bowel, is useful diagnostic modality for SBCD. The results of a Spanish national survey showed that SBCE is widely used to manage IBD in patients with SCD (76.3%), to assess inflammatory activity (54.7%) and to evaluate the extent of disease (54.7%) [ 15 ]. In addition, CE has been shown to be useful in assessing mucosal CD activity in selected patients with colonic CD [ 16 ].…”

Section: Crohn’s Diseasementioning

confidence: 99%

Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom?

Lim

2021

Diagnostics

View full text Add to dashboard Cite

Capsule endoscopy (CE) has proven to be a valuable diagnostic modality for small bowel diseases over the past 20 years, particularly Crohn’s disease (CD), which can affect the entire gastrointestinal tract from the mouth to the anus. CE is not only used for the diagnosis of patients with suspected small bowel CD, but can also be used to assess disease activity, treat-to-target, and postoperative recurrence in patients with established small bowel CD. As CE can detect even mildly non-specific small bowel lesions, a high diagnostic yield is not necessarily indicative of high diagnostic accuracy. Moreover, the cost effectiveness of CE as a third diagnostic test employed usually after ileocolonoscopy and MR or CT enterography is an important consideration. Recently, new developments in colon capsule endoscopy (CCE) have increased the utility of CE in patients with ulcerative colitis (UC) and pan-enteric CD. Although deflation of the colon during the examination and the inability to evaluate dysplasia-associated lesion or mass results in an inherent risk of overestimation or underestimation, the convenience of CCE examination and the risk of flare-up after colonoscopy suggest that CCE could be used more actively in patients with UC.

show abstract

Use of capsule endoscopy in inflammatory bowel disease in clinical practice in Spain. Results from a national survey

Cited by 2 publications

References 24 publications

Capsule Endoscopy in Inflammatory Bowel Disease: A Systematic Review

Capsule Endoscopy in Inflammatory Bowel Disease: A Systematic Review

Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom?

Contact Info

Product

Resources

About